Detalhe da pesquisa
1.
Dendritic cell vaccines extend CAR T-cell persistence and improve the efficacy of CD19 CAR T-cell therapy in refractory or relapsed adult B-ALL patients.
Am J Hematol;
99(7): 1437-1440, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38712616
2.
Chinese expert consensus on integrated case management by a multidisciplinary team in CAR-T cell therapy for lymphoma.
Chin Med J (Engl);
2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38570196
3.
Risk-directed therapy based on genetics and MRD improves the outcomes of AML1-ETO-positive AML patients, a multi-center prospective cohort study.
Blood Cancer J;
13(1): 168, 2023 11 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37957175
4.
Impact of genetic patterns on sorafenib efficacy in patients with FLT3-ITD acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation: a multi-center, cohort study.
Signal Transduct Target Ther;
8(1): 348, 2023 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37704613
5.
Donor-derived CAR-T therapy improves the survival of relapsed B-ALL after allogeneic transplantation compared with donor lymphocyte infusion.
Hum Cell;
36(5): 1716-1728, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37418233
6.
Sorafenib maintenance after allogeneic haemopoietic stem-cell transplantation in patients with FLT3-ITD acute myeloid leukaemia: long-term follow-up of an open-label, multicentre, randomised, phase 3 trial.
Lancet Haematol;
10(8): e600-e611, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414062
7.
Early granulocyte colony stimulating factor administration increases the risk of cytokine release syndrome in acute lymphoblastic leukemia patients receiving anti-CD19 chimeric antigen receptor T-cell therapy.
Hematol Oncol;
41(5): 933-941, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37259483
8.
2022 Chinese expert consensus and guidelines on clinical management of toxicity in anti-CD19 chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma.
Cancer Biol Med;
20(2)2023 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36861439
9.
Effect of sorafenib maintenance on Epstein-Barr virus and cytomegalovirus infections in patients with FLT3-ITD AML undergoing allogeneic hematopoietic stem cell transplantation: a secondary analysis of a randomized clinical trial.
BMC Med;
20(1): 282, 2022 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36050712
10.
Donor-derived and off-the-shelf allogeneic anti-CD19 CAR T-cell therapy for R/R ALL and NHL: A systematic review and meta-analysis.
Crit Rev Oncol Hematol;
179: 103807, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36087853
11.
Combination strategies to optimize the efficacy of chimeric antigen receptor T cell therapy in haematological malignancies.
Front Immunol;
13: 954235, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36091028
12.
[Efficacy and Safety of Cladribine-based Intensified Conditioning Regimen in Hematopoietic Stem Cell Transplantation in Patients with High-Risk Acute Myeloid Leukemia].
Zhongguo Shi Yan Xue Ye Xue Za Zhi;
30(1): 65-71, 2022 Feb.
Artigo
em Chinês
| MEDLINE | ID: mdl-35123605
13.
The role of allogeneic haematopoietic cell transplantation as consolidation after anti-CD19 CAR-T cell therapy in adults with relapsed/refractory acute lymphoblastic leukaemia: a prospective cohort study.
Bone Marrow Transplant;
57(3): 513-516, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35058582
14.
Current state of CAR-T therapy for T-cell malignancies.
Ther Adv Hematol;
13: 20406207221143025, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36601636
15.
Design, synthesis, and biological evaluation of Bcr-Abl PROTACs to overcome T315I mutation.
Acta Pharm Sin B;
11(5): 1315-1328, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34094836
16.
Consolidative Hematopoietic Stem Cell Transplantation After CD19 CAR-T Cell Therapy for Acute Lymphoblastic Leukemia: A Systematic Review and Meta-analysis.
Front Oncol;
11: 651944, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34026627
17.
Preclinical and clinical advances in dual-target chimeric antigen receptor therapy for hematological malignancies.
Cancer Sci;
112(4): 1357-1368, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33416209
18.
Phase I Trial of Fourth-Generation Anti-CD19 Chimeric Antigen Receptor T Cells Against Relapsed or Refractory B Cell Non-Hodgkin Lymphomas.
Front Immunol;
11: 564099, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33329526
19.
[Efficacy and Prognosis of Allogeneic Hematopoietic Stem Cell Transplantation for Acute Monocytic Leukemia Patients].
Zhongguo Shi Yan Xue Ye Xue Za Zhi;
28(6): 1859-1866, 2020 Dec.
Artigo
em Chinês
| MEDLINE | ID: mdl-33283711
20.
Dual targeting of NUAK1 and ULK1 using the multitargeted inhibitor MRT68921 exerts potent antitumor activities.
Cell Death Dis;
11(8): 712, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32873786